Management of acute loss of asthma control in the yellow zone: a practice parameter

Ann Allergy Asthma Immunol. 2014 Aug;113(2):143-59. doi: 10.1016/j.anai.2014.05.017.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Acetates / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-2 Receptor Agonists / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / therapy
  • Bronchodilator Agents / therapeutic use*
  • Humans
  • Leukotriene Antagonists / therapeutic use
  • Nebulizers and Vaporizers*
  • Quinolines / therapeutic use
  • Respiratory Tract Infections / therapy
  • Self Care / methods*

Substances

  • Acetates
  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Leukotriene Antagonists
  • Quinolines
  • montelukast